{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:56:08Z","timestamp":1768434968414,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.path.2024.08.004","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T16:39:54Z","timestamp":1727282394000},"page":"53-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Updates on Urothelial Carcinoma of the Upper Urinary Tract with a Focus on Molecular Findings"],"prefix":"10.1016","volume":"18","author":[{"given":"Eva","family":"Comp\u00e9rat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kl\u00e4ger","family":"Johannes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shariat","family":"Shahrokh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasinger","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.path.2024.08.004_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European association of Urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.path.2024.08.004_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.urolonc.2022.08.010","article-title":"Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy","volume":"40","author":"Takemoto","year":"2022","journal-title":"Urol Oncol"},{"issue":"11","key":"10.1016\/j.path.2024.08.004_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrurol.2017.125","article-title":"Characteristics and clinical significance of histological variants of bladder cancer","volume":"14","author":"Moschini","year":"2017","journal-title":"Nat Rev Urol"},{"issue":"5","key":"10.1016\/j.path.2024.08.004_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clgc.2023.05.011","article-title":"Impact of variant histology on oncological outcomes in upper tract urothelial carcinoma: results from the ROBUUST collaborative group","volume":"21","author":"Douglawi","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.path.2024.08.004_bib5","series-title":"The Paris System for reporting urinary cytology [internet]","author":"Wojcik","year":"2022"},{"issue":"4","key":"10.1016\/j.path.2024.08.004_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cncy.22343","article-title":"A review of upper urinary tract cytology performance before and after the implementation of The Paris System","volume":"129","author":"Zhang","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.path.2024.08.004_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2016.04.030","article-title":"Diagnostic utility of selective upper tract urinary cytology: a systematic review and meta-analysis of the literature","volume":"96","author":"Potretzke","year":"2016","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.path.2024.08.004_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/cancers12030763","article-title":"Pure large nested variant of urothelial carcinoma (LNUC) is the prototype of an FGFR3 mutated aggressive urothelial carcinoma with luminal-papillary phenotype","volume":"12","author":"Weyerer","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.path.2024.08.004_bib9","doi-asserted-by":"crossref","first-page":"100333","DOI":"10.1016\/j.modpat.2023.100333","article-title":"Nested and large nested subtypes of urothelial carcinoma of the upper urinary tract: a multi-institutional study","volume":"36","author":"Aron","year":"2023","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2024.08.004_bib10","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41467-019-10873-y","article-title":"Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling","volume":"10","author":"Robinson","year":"2019","journal-title":"Nat Commun"},{"issue":"17","key":"10.1016\/j.path.2024.08.004_bib11","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.3390\/cancers13174341","article-title":"Efficacy of immune checkpoint inhibitors in upper tract urothelial carcinomas: current knowledge and future directions","volume":"13","author":"Thouvenin","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.path.2024.08.004_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.21873\/cgp.20435","article-title":"Association of androgen receptor and PD-L1 expression in upper urinary tract urothelial carcinoma","volume":"21","author":"Okuda","year":"2024","journal-title":"Cancer Genomics Proteomics"},{"issue":"4","key":"10.1016\/j.path.2024.08.004_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","article-title":"Comprehensive genomic characterization of upper tract urothelial carcinoma","volume":"72","author":"Moss","year":"2017","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.path.2024.08.004_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ccell.2021.05.008","article-title":"Molecular classification and diagnostics of upper urinary tract urothelial carcinoma","volume":"39","author":"Fujii","year":"2021","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.path.2024.08.004_bib15","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-18-2039","article-title":"Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma","volume":"25","author":"Audenet","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.path.2024.08.004_bib16","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1038\/s41467-024-46320-w","article-title":"The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis","volume":"15","author":"Ohara","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.path.2024.08.004_bib17","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.juro.2016.01.006","article-title":"Genomic biomarkers for the prediction of stage and prognosis of upper tract urothelial carcinoma","volume":"195","author":"Bagrodia","year":"2016","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.path.2024.08.004_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.euf.2018.01.005","article-title":"Genomic profile of urothelial carcinoma of the upper tract from ureteroscopic biopsy: feasibility and validation using matched radical nephroureterectomy specimens","volume":"5","author":"Bagrodia","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"7","key":"10.1016\/j.path.2024.08.004_bib19","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.3390\/ijms25073695","article-title":"Prognostic value of liquid-biopsy-based biomarkers in upper tract urothelial carcinoma","volume":"25","author":"Padull\u00e9s","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.path.2024.08.004_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tips.2019.01.006","article-title":"Liquid biopsies in cancer diagnosis, monitoring, and prognosis","volume":"40","author":"De","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"18","key":"10.1016\/j.path.2024.08.004_bib22","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa043146","article-title":"Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)","volume":"352","author":"Hampel","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.path.2024.08.004_bib23","doi-asserted-by":"crossref","first-page":"738274","DOI":"10.1155\/2012\/738274","article-title":"Endometrial cancer and hypermethylation: regulation of DNA and MicroRNA by epigenetics","volume":"2012","author":"Banno","year":"2012","journal-title":"Biochem Res Int"},{"issue":"10","key":"10.1016\/j.path.2024.08.004_bib24","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/ajg.2011.203","article-title":"Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion","volume":"106","author":"Lynch","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.path.2024.08.004_bib25","doi-asserted-by":"crossref","first-page":"103178","DOI":"10.1016\/j.dnarep.2021.103178","article-title":"Tissue-specific reduction in MLH1 expression induces microsatellite instability in intestine of Mlh1+\/- mice","volume":"106","author":"Shrestha","year":"2021","journal-title":"DNA Repair (Amst)"},{"issue":"2","key":"10.1016\/j.path.2024.08.004_bib27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/cancers15020506","article-title":"Relative risk of bladder and kidney cancer in lynch syndrome: systematic review and meta-analysis","volume":"15","author":"Nassour","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.path.2024.08.004_bib28","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.juro.2010.12.102","article-title":"Upper urinary tract carcinoma in Lynch syndrome cases","volume":"185","author":"Crockett","year":"2011","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.path.2024.08.004_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAP.0b013e31817145a9","article-title":"Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting","volume":"15","author":"Gupta","year":"2008","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1016\/j.path.2024.08.004_bib30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/hupa.2003.22","article-title":"Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability","volume":"34","author":"Hartmann","year":"2003","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.path.2024.08.004_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.path.2024.08.004_bib32","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.path.2024.08.004_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/modpathol.2016.171","article-title":"Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome","volume":"30","author":"Harper","year":"2017","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.path.2024.08.004_bib34","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/j.clgc.2020.03.006","article-title":"Loss of mismatch-repair protein expression and microsatellite instability in upper tract urothelial carcinoma and clinicopathologic implications","volume":"18","author":"Schneider","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.path.2024.08.004_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.urology.2022.02.006","article-title":"Immunohistochemical screening of upper tract urothelial carcinomas for lynch syndrome diagnostics: a systematic review","volume":"165","author":"Rasmussen","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.path.2024.08.004_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2407-5-23","article-title":"Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma","volume":"5","author":"Ericson","year":"2005","journal-title":"BMC Cancer"},{"issue":"39","key":"10.1016\/j.path.2024.08.004_bib37","first-page":"70","article-title":"Testing for microsatellite instability in colorectal cancer - a comparative evaluation of immunohistochemical and molecular methods","volume":"1","author":"Vg","year":"2022","journal-title":"Gulf J Oncolog"},{"key":"10.1016\/j.path.2024.08.004_bib38","doi-asserted-by":"crossref","first-page":"e2300697","DOI":"10.1200\/PO.23.00697","article-title":"Inherited germline variants in urinary tract cancer: a multicenter whole-exome sequencing analysis and correlation with clinical features and tumor genomics","volume":"8","author":"Kohlmann","year":"2024","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.path.2024.08.004_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MOU.0000000000000340","article-title":"Lynch syndrome in upper tract urothelial carcinoma: significance, screening, and surveillance","volume":"27","author":"Pradere","year":"2017","journal-title":"Curr Opin Urol"},{"issue":"4","key":"10.1016\/j.path.2024.08.004_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10689-008-9193-9","article-title":"Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer","volume":"7","author":"Myrh\u00f8j","year":"2008","journal-title":"Fam Cancer"},{"issue":"10232","key":"10.1016\/j.path.2024.08.004_bib42","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"u. a. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.path.2024.08.004_bib43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.eururo.2020.07.003","article-title":"Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and future perspectives on systemic therapy","volume":"79","author":"Leow","year":"2021","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.path.2024.08.004_bib46","doi-asserted-by":"crossref","first-page":"e001246","DOI":"10.1136\/jitc-2020-001246","article-title":"Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis","volume":"8","author":"Apolo","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.path.2024.08.004_bib47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/curroncol29020060","article-title":"Current advances in immune checkpoint inhibition and clinical genomics in upper tract urothelial carcinoma: state of the art","volume":"29","author":"Califano","year":"2022","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.path.2024.08.004_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/iju5.12542","article-title":"A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome","volume":"6","author":"Oki","year":"2023","journal-title":"IJU Case Rep"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918124000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918124000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:31:21Z","timestamp":1760074281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918124000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1875918124000540"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2024.08.004","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on Urothelial Carcinoma of the Upper Urinary Tract with a Focus on Molecular Findings","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2024.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}